[1] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
[2] LI L,JIANG W,WANG J Y.Clinical analysis of 275 cases of acute drug-induced liver disease[J].Front Med China,2007,1(1):58-61.
[3] BJÖRNSSON E S.Epidemiology and risk factors for idiosyncratic drug-induced liver injury[J].Semin Liver Dis,2014,34(2):115-122.
[4] WHO.Global Tuberculosis Report2017[R/OL].2017-12[2018-02-18].
[5] ZHANG S M,PAN H Q,PENG X Z,et al.Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury:A randomized controlled trial[J].J Gastroenterol Hepatol,2016,31(2):409-416.
[6] CHANG T E,HUANG Y S,CHANG C H,et al.The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection:A systematic review and meta-analysis[J].J Chin Med Assoc,2018,81(2):111-118.
[7] 李仁仙.异甘草酸镁治疗药物性肝炎50例临床分析[J].亚太传统医药,2011,7(8):75-76.
[8] 付贵化,朱红辉,陈红艳.异甘草酸镁治疗结核药物引起药物性肝炎临床观察[J].医药前沿,2012,2:132-133.
[9] 高卫红,邵伟杰,雷涛.异甘草酸镁治疗抗结核药物性肝损伤45例[J].中国药业,2013,22(11):122-123.
[10] 邓敏,宣华,余晓,等.异甘草酸镁联合谷胱甘肽治疗抗结核药物所致中度以上肝损害疗效观察[J].浙江实用医学,2013,18(3):177-178.
[11] 郭新枝,陈裕,程俊伟,等.异甘草酸镁注射液治疗抗结核药物所致急性肝损伤的临床研究[J].微生物与感染,2013,8(3):157-162.
[12] 田红华,汪水香.异甘草酸镁治疗抗结核药物引起的药物性肝炎临床疗效观察[J].医药前沿,2014,12:26-27.
[13] 陈永芳,程俊伟,陈裕,等.异甘草酸镁注射液治疗抗结核药物所致急性肝损伤的疗效分析[J].北京医学,2014,36(3):223-225.
[14] 熊延军,李东方,孙红,等.异甘草酸镁治疗抗结核药物性肝损害的效果分析[J].中国当代医药,2014,21(5):68-69,72.
[15] 吴小霞,辛朝雄,李晓云,等.异甘草酸镁治疗抗结核药引起的药物性肝炎的疗效分析[J].现代诊断与治疗,2015,26(6):1272-1274.
[16] 白龙.异甘草酸镁治疗结核药物性肝损害的疗效观察[J].临床医药文献杂志,2015,2(27):5724-5726.
[17] LIMAMD E F,MELO H R.Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis[J].Cad Saude Publica,2012,28(4):698-708.
[18] RANGNEKAR A S,FONTANA R J.An update on drug induced liver injury[J].Minerva Gastroenterol Dietol,2011,57(2):213-229.
[19] MANNS M P,WEDEMEYER H,SINGER A,et al.Glycyrrhizin in patients who failed previous interferon alpha-based therapies:biochemical and histological effects after 52 weeks[J].J Viral Hepat,2012,19(8):537-546.